Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm D Mason

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
European Urology|January 31, 2022
Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?Malcolm D Mason, Theodorus H van der Kwast, Nicolas Mottet, et al.
BJU International|February 9, 2012
Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic reviewMike D Shelley, Gabriel Jones, Anne Cleves, et al.
Journal of Cellular Physiology|May 2, 2008
Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisationAndrew J Sanders, Christian Parr, Tracey A Martin, et al.
Journal of Translational Medicine|January 14, 2009
Can urinary exosomes act as treatment response markers in prostate cancer?Paul J Mitchell, Joanne Welton, John Staffurth, et al.
Oncotarget|March 3, 2016
Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypesJason P Webber, Lisa K Spary, Malcolm D Mason, et al.
International Journal of Oncology|October 4, 2006
Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significanceGaynor Davies, Khaled A Rmali, Gareth Watkins, et al.
European Urology|May 10, 2011
The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literatureGuru Sonpavde, Gerhardt Attard, Joaquim Bellmunt, et al.
BJU International|May 17, 2005
A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinomaRob J Skyrme, A Jane French, Shibendra N Datta, et al.
Urologic Oncology|March 28, 2008
Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cellsGaynor Davies, Tracey A Martin, Lin Ye, et al.
Urologic Oncology|June 15, 2012
Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cellsLin Ye, Ping-Hui Sun, Tracey A Martin, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
European Urology|January 31, 2022
Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?Malcolm D Mason, Theodorus H van der Kwast, Nicolas Mottet, et al.
BJU International|February 9, 2012
Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic reviewMike D Shelley, Gabriel Jones, Anne Cleves, et al.
Journal of Cellular Physiology|May 2, 2008
Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisationAndrew J Sanders, Christian Parr, Tracey A Martin, et al.
Journal of Translational Medicine|January 14, 2009
Can urinary exosomes act as treatment response markers in prostate cancer?Paul J Mitchell, Joanne Welton, John Staffurth, et al.
Oncotarget|March 3, 2016
Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypesJason P Webber, Lisa K Spary, Malcolm D Mason, et al.
International Journal of Oncology|October 4, 2006
Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significanceGaynor Davies, Khaled A Rmali, Gareth Watkins, et al.
European Urology|May 10, 2011
The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literatureGuru Sonpavde, Gerhardt Attard, Joaquim Bellmunt, et al.
BJU International|May 17, 2005
A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinomaRob J Skyrme, A Jane French, Shibendra N Datta, et al.
Urologic Oncology|March 28, 2008
Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cellsGaynor Davies, Tracey A Martin, Lin Ye, et al.
Urologic Oncology|June 15, 2012
Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cellsLin Ye, Ping-Hui Sun, Tracey A Martin, et al.
Pageof 15